Hello, everyone, and how are you today? Tis another busy morning on the Pharmalot corporate campus, where the shortest of short people is being hustled out the door to the local schoolhouse and the official Pharmalot mascots are fertilizing our collection of weeds. Meanwhile, we are downing another delicious cup of stimulation and planning another busy day. We know you can relate. So, let us proceed. Here are some tidbits to get you going. Hope all goes well and you conquer the world...
Vertex Pharma Gets A New CEO (Xconomy)
Novartis Says No Safety Worries In Late-Stage Gilenya Trial (Reuters)
Hospitals Adopt Pharma Sales Strategies (Kaiser Health News)
Covidien To Spin Off Pharma Business (Reuters)
VA May Have Improperly Spent Billions On Meds & Other Items (Bloomberg News)
Could Statins Help People With The Flu? (HealthDay News)
Fat-Burning Roche Drug Stopped Diabetes In Mice (Bloomberg News)
Asian CROs Form A Regional Alliance (Outsourcing Pharma)
Roche Price Cut Wins NICE OK For RoActemra (Pharma Times)
Drugmakers Halt Supplies To Hospitals Over Unpaid Bills (Indian Express)
EDITOR'S NOTE: Please check this post for updates throughout the morning